A randomized, double-blind, placebo-controlled pilot trial of triiodothyronine in neonatal heart surgery

Triiodothyronine supplementation was safe and resulted in more rapid achievement of negative fluid balance after aortic arch reconstruction. Cardiac index at 48 hours was not significantly improved.